Not logged in Share Save
Share Save
Share Save
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019 Yamamoto, Chie; Taniguchi, Masashi; Furukawa, Keitaro; Inaba, Toru; Niiyama, Yui; Ide, Daisuke; Mizutani, Shinsuke; Kuroda, Junya; Tanino, Yoko; Nishioka, Keisuke; Watanabe, Yohei; Takayama, Koichi; Nakaya, Takaaki; Nukui, Yoko Share Save
Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma Niiyama-Uchibori, Yui; Okamoto, Haruya; Miyashita, Akihiro; Mizuhara, Kentaro; Kanayama-Kawaji, Yuka; Fujino, Takahiro; Tsukamoto, Taku; Mizutani, Shinsuke; Shimura, Yuji; Teramukai, Satoshi; Kuroda, Junya Share Save
Share Save
Share Save
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma Okamoto, Haruya; Uoshima, Nobuhiko; Muramatsu, Ayako; Isa, Reiko; Fujino, Takahiro; Matsumura-Kimoto, Yayoi; Tsukamoto, Taku; Mizutani, Shinsuke; Shimura, Yuji; Kobayashi, Tsutomu; Kawata, Eri; Uchiyama, Hitoji; Kuroda, Junya Share Save
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder Nagata, Hiroaki; Kuriyama, Kodai; Nishikawa, Rina; Ohshiro, Muneo; Yamamoto-Sugitani, Mio; Fujimoto-Hirakawa, Yoshiko; Matsumoto, Yosuke; Iwai, Toshiki; Tsukamoto, Taku; Mizutani, Shinsuke; Shimura, Yuji; Kobayashi, Tsutomu; Fukuda, Wataru; Uchiyama, Hitoji; Kuroda, Junya Share Save
Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations Okamoto, Haruya; Uoshima, Nobuhiko; Kamitsuji, Yuri; Kawata, Eri; Komori, Yukiko; Sasaki, Nana; Tsutsumi, Yasuhiko; Tsukamoto, Taku; Mizutani, Shinsuke; Nannya, Yasuhito; Kuroda, Junya Share Save
Finding critical cancer driving and cancer suppressing genes using functional genomics screening in vivo Herold, Marco Josef; Mizutani, Shinsuke; Deng, Yexuan; Janic, Ana; Kueh, Andrew; Pal, Martin; Wilcox, Stephen; Tai, Lin; Kelly, Gemma L.; Strasser, Andreas Share Save
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma Isa, Reiko; Uoshima, Nobuhiko; Takahashi, Ryoichi; Nakano-Akamatsu, Sonoko; Kawata, Eri; Kaneko, Hiroto; Shimura, Kazuho; Kamitsuji, Yuri; Takimoto-Shimomura, Tomoko; Mizutani, Shinsuke; Chinen, Yoshiaki; Ohshiro, Muneo; Fujino, Takahiro; Kawaji, Yuka; Uchiyama, Hitoji; Sasaki, Nana; Tsukamoto, Taku; Shimura, Yuji; Kobayashi, Tsutomu; Taniwaki, Masafumi; Kuroda, Junya Share Save
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2 Takimoto-Shimomura, Tomoko; Tsukamoto, Taku; Maegawa, Saori; Fujibayashi, Yuto; Matsumura-Kimoto, Yayoi; Mizuno, Yoshimi; Chinen, Yoshiaki; Shimura, Yuji; Mizutani, Shinsuke; Horiike, Shigeo; Taniwaki, Masafumi; Kobayashi, Tsutomu; Kuroda, Junya Share Save
High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif Tsukamoto, Taku; Nakano, Masakazu; Sato, Ryuichi; Adachi, Hiroko; Kiyota, Miki; Kawata, Eri; Uoshima, Nobuhiko; Yasukawa, Satoru; Chinen, Yoshiaki; Mizutani, Shinsuke; Shimura, Yuji; Kobayashi, Tsutomu; Horiike, Shigeo; Yanagisawa, Akio; Taniwaki, Masafumi; Tashiro, Kei; Kuroda, Junya Share Save
Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma Chinen, Yoshiaki; Kuroda, Junya; Shimura, Yuji; Nagoshi, Hisao; Kiyota, Miki; Yamamoto-Sugitani, Mio; Mizutani, Shinsuke; Sakamoto, Natsumi; Ri, Masaki; Kawata, Eri; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Iida, Shinsuke; Taniwaki, Masafumi Share Save
8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia Chinen, Yoshiaki; Sakamoto, Natsumi; Nagoshi, Hisao; Taki, Tomohiko; Maegawa, Saori; Tatekawa, Shotaro; Tsukamoto, Taku; Mizutani, Shinsuke; Shimura, Yuji; Yamamoto-Sugitani, Mio; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Kuroda, Junya; Taniwaki, Masafumi Share Save
Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy Kuroda, Junya; Mizutani, Shinsuke; Shimura, Yuji; Maegawa, Saori; Nagoshi, Hisao; Chinen, Yoshiaki; Tatekawa, Shotaro; Tsukamoto, Taku; Mizuno, Yoshimi; Yamamoto-Sugitani, Mio; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Taniwaki, Masafumi Share Save
FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors Kiyota, Miki; Kuroda, Junya; Yamamoto-Sugitani, Mio; Shimura, Yuji; Nakayama, Ryuko; Nagoshi, Hisao; Mizutani, Shinsuke; Chinen, Yoshiaki; Sasaki, Nana; Sakamoto, Natsumi; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Taniwaki, Masafumi Share Save
RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma Shimura, Yuji; Kuroda, Junya; Ri, Masaki; Nagoshi, Hisao; Yamamoto-Sugitani, Mio; Kobayashi, Tsutomu; Kiyota, Miki; Nakayama, Ryuko; Mizutani, Shinsuke; Chinen, Yoshiaki; Sakamoto, Natsumi; Matsumoto, Yosuke; Horiike, Shigeo; Shiotsu, Yukimasa; Iida, Shinsuke; Taniwaki, Masafumi Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
